Private Equity’s Senator Gets Big Payout

Key phrases

Older messages

LEVER WEEKLY: Shadowbanning An Inconvenient Truth

Sunday, February 26, 2023

On rail safety, the partisan ghost is still haunting the media machine. LEVER WEEKLY: Shadowbanning An Inconvenient Truth By The Lever – 26 Feb 2023 – View online → Joe Biden and Barack Obama. (AP

DeWine's Toxic Railroad Ties

Friday, February 24, 2023

Ohio Gov. Mike DeWine's track record and rail company links raise questions about his ability to hold the rail giant accountable for the derailment disaster. DeWine's Toxic Railroad Ties By The

The Left Bank’s Warning About Wall Street

Thursday, February 23, 2023

An obscure rare book scandal offers a cautionary tale about public pensions' growing reliance on private equity. The Left Bank's Warning About Wall Street By The Lever – 23 Feb 2023 – View

How The Lever Forced Buttigieg To Do His Job

Wednesday, February 22, 2023

We scrutinize Transportation Secretary Pete Buttigieg's new tough talk about improved railroad safety rules. How The Lever Forced Buttigieg To Do His Job By The Lever – 22 Feb 2023 – View online →

Enviros Threaten Legal Action If Buttigieg Doesn’t Act

Tuesday, February 21, 2023

Organizations demand the Transportation Secretary revisit a repealed brake safety rule, or else they “will consider taking legal action.” Enviros Threaten Legal Action If Buttigieg Doesn't Act By

You Might Also Like

EU tells Meta it can't paywall privacy [Fri Apr 19 2024]

Friday, April 19, 2024

Hi The Register Subscriber | Log in The Register {* Daily Headlines *} 19 April 2024 facebook EU tells Meta it can't paywall privacy Platforms should not confront users with 'binary choice'

What A Day: Fury selection

Friday, April 19, 2024

Lawyers in Trump's Manhattan hush money trial have assembled a jury. God help them. ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

🛑 Stop, collaborate, and listen to the sound of yourself clicking these sweet links

Friday, April 19, 2024

Fun stuff to click on, watch, and read from CreativeMornings HQ. April 18, 2024 Open in new tab Did a friend forward this? Subscribe today. Speech bubble logo with the words, CreativeMornings "If

My Relentless Journey to Find the Perfect White Tee

Friday, April 19, 2024

Here's What You Missed on the Strategist The Strategist Every product is independently selected by editors. If you buy something through our links, New York may earn an affiliate commission. My

How To Profit From The Upcoming Bitcoin Halving

Thursday, April 18, 2024

Exclusive offer to join Forbes Crypto Advisor View in browser Did you attend Decoding Bitcoin Halving 2024? Now's your chance to ACT on the insights! The clock is ticking. Tomorrow, April 19,

Why Are Republicans Suddenly Sounding So Pro-Choice?

Thursday, April 18, 2024

Columns and commentary on news, politics, business, and technology from the Intelligencer team. Intelligencer life after roe Why Are Republicans Suddenly Sounding So Pro-Choice? Maybe it's because

All printers suck

Thursday, April 18, 2024

But this one sucks the least ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

Friday Briefing: India’s election begins

Thursday, April 18, 2024

Also, new Western sanctions on Iran, and China's sinking cities. View in browser|nytimes.com Continue reading the main story Ad Morning Briefing: Asia Pacific Edition April 19, 2024 Author Headshot

Johnson Comes Around

Thursday, April 18, 2024

Ukraine Aid, Jury Doody ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

A potential ‘slam the brakes’ moment for climate tech | Shein popping up in Seattle

Thursday, April 18, 2024

Wizards of the Coast president resigns | NanoString to be acquired for $392M ADVERTISEMENT GeekWire SPONSOR MESSAGE: Science Firsthand: Learn how Bristol Myers Squibb unlocked the potential of CAR T